SCHEMBL5282505

SCHEMBL5282505

O=C(Cc1cc(-c2ccccc2)on1)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.51
PPARA Q07869 1/20 0.47
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 4/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NPC1 O15118 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12002394 0.82 NOTUM (0.58) NOTUMPPARARAB9ASMN1; SMN2ALDH1A1
SCHEMBL27163685 0.80 NOTUM (0.55) NOTUMPPARARAB9ASMN1; SMN2ALDH1A1
SCHEMBL6964641 0.80 NOTUM (0.58) NOTUMPPARARAB9ASMN1; SMN2ALDH1A1
SCHEMBL5290844 0.79 MAPT (0.61) RAB9ASMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL5283705 0.77 NOTUM (0.67) NOTUMPPARARAB9ASMN1; SMN2ALDH1A1
SCHEMBL5286842 0.77 NOTUM (0.51) NOTUMRAB9ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL5285087 0.77 ALDH1A1 (0.57) RAB9ASMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL5283814 0.74 LMNA (0.53) PPARAALDH1A1LMNAHPGDKMT2A
SCHEMBL31225490 0.72 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1LMNAMEN1KMT2A
SCHEMBL6937307 0.71 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1L3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 NOTUM 3506/4885PPARA 2245/4885RAB9A 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.